Revisiting the rules for anatomical targeting of ventralis intermediate nucleus.


Journal

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
ISSN: 1532-2653
Titre abrégé: J Clin Neurosci
Pays: Scotland
ID NLM: 9433352

Informations de publication

Date de publication:
Oct 2019
Historique:
received: 14 02 2019
revised: 23 05 2019
accepted: 06 07 2019
pubmed: 23 7 2019
medline: 4 12 2019
entrez: 23 7 2019
Statut: ppublish

Résumé

Indirect targeting of the Ventralis Intermedius Nucleus (Vim) is widely used for functional neurosurgical procedures to treat essential tremor (ET). Here, we review if the laterality of the Vim depends on the diameter of the third ventricle and if a targeting approach that incorporates this correlation can facilitate targeting and yields accurate lead placement. We analyzed 15 consecutive ET patients. Vim targeting was adapted according to the width of the third ventricle and the lateral distance to the internal capsule (IC). Postoperative outcome was assessed 12 months post-OP based on the Bain-Findley score. Application of this targeting approach resulted in mean target coordinates of LAT 12.8 ± 1.5; AP -3.6 ± 1.0 and VERT 0 ± 0 mm and which projected onto the Vim. The laterality of IC and Vim are correlated to the width of the third ventricle. The mean postoperative tremor reduction was 63.0%. In summary, adjusting the lateral coordinate according to the width of the third ventricle leads to accurate targeting and effective tremor reduction.

Identifiants

pubmed: 31327590
pii: S0967-5868(19)30302-9
doi: 10.1016/j.jocn.2019.07.027
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

97-100

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Andreas Nowacki (A)

Department of Neurosurgery, Oxford University Hospital Foundation Trust, Oxford, United Kingdom. Electronic address: neuro.nowacki@gmail.com.

Marko Bogdanovic (M)

Department of Neurology, Oxford University Hospital Foundation Trust, Oxford, United Kingdom.

Nagaraja Sarangmat (N)

Department of Neurology, Oxford University Hospital Foundation Trust, Oxford, United Kingdom.

James Fitzgerald (J)

Nuffield Department of Clinical Neuroscience, University of Oxford, Oxford, United Kingdom.

Alex Green (A)

Nuffield Department of Clinical Neuroscience, University of Oxford, Oxford, United Kingdom.

Tipu Z Aziz (TZ)

Nuffield Department of Clinical Neuroscience, University of Oxford, Oxford, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH